Assyro AI

Orange Book product · Generic (ANDA)

SILDENAFIL CITRATE

SILDENAFIL CITRATE

Generic (ANDA)ANDA 201171DISCN MYLAN
View SILDENAFIL CITRATE familyOpen on FDA Orange Book

At a glance

Mar 25, 2019

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 25, 2019

    7 yr 4 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SILDENAFIL CITRATE

Strength

EQ 25MG BASE

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 201171

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SILDENAFIL CITRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo